Αρχική World News EMA Recommends Extension of Indications for Serplulimab World News EMA Recommends Extension of Indications for Serplulimab Από Ogkologos - 22 Απριλίου, 2026 344 0 Facebook Twitter Google+ Pinterest WhatsApp New indications concern the treatment of patients with oesophageal squamous cell carcinoma and non-small cell lung cancer Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Mom Births Stillborn Baby But Never Anticipated Nurse’s Remark She Will... 15 Μαρτίου, 2019 FDA Approves Treosulfan with Fludarabine As a Preparative Regimen for alloHSCT... 13 Μαρτίου, 2025 Weight Loss Treatments Linked to Lower Risk of Obesity-Related Cancers in... 8 Ιουνίου, 2026 Fostering Black leadership in cancer research 20 Ιουλίου, 2023 Φόρτωση περισσοτέρων HOT NEWS Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish... TILs Therapy Shows Promise in the Management of Anti-PD-1-Resistant Metastatic NSCLC Woman Donates 500 Care Packages To Breast Cancer Patients Seven Ways an Occupational Therapist Can Help Patients Recovering From Breast...